Emerald Bioscience, Inc. (61) | Development Agreements (2)
- First Amendment to Master Development and Clinical Supply Agreement, dated as of August 7, 2019 by and between the Company and Noramco (Filed With SEC on August 8, 2019)
- Master Development and Clinical Supply Agreement, dated February 26, 2019, by and between Nemus Bioscience, Inc. and Noramco, Inc (Filed With SEC on March 4, 2019)
